What side effects may be caused by benzalantamine, and how to deal with it?

Bengalantamine, as a new cholinesterase inhibitor, has been widely used in the treatment of mild to moderate dementia in adults with Alzheimer's disease. This drug effectively inhibits the activity of cholinesterase and increases the concentration of acetylcholine in the brain, thereby improving the patient's cognitive function and bringing new treatment hope to many patients with Alzheimer's disease. However, any drug may be accompanied by a series of side effects while exerting its therapeutic effect, and benzalantamine is no exception. Therefore, patients must fully understand its possible side effects before use and develop corresponding coping strategies.

Common side effects of benzalantamine include nausea, vomiting, diarrhea, dizziness, headache, and decreased appetite. These symptoms are usually more noticeable in the early stages of medication and may have a certain impact on the patient's daily life. Fortunately, as the medication time is extended, some patients can gradually adapt and these symptoms will be relieved. However, if the side effects continue to be severe or affect the patient's quality of life, the patient should communicate with the doctor in time and consider adjusting the drug dosage or replacing other treatment drugs to ensure the smooth progress of the treatment.

In addition to the common side effects mentioned above, benzalantamine may also cause some serious side effects, which require patients to be particularly vigilant. There have been reports of severe skin reactions in individual patients treated with galantamine (bengalantamine's active metabolite in the body). Therefore, patients should closely observe their skin conditions during medication. Once any signs or symptoms suggestive of severe skin reactions occur, they should stop medication immediately and seek medical treatment in a timely manner to seek alternative treatment options.

On the cardiovascular system, benzalantamine may have a vagal excitatory effect on the sinoatrial and atrioventricular nodes, resulting in bradycardia or heart block. This is a matter of close concern in patients with or without known cardiac conduction abnormalities. Patients should undergo regular electrocardiogram examinations during medication to detect and deal with any abnormalities in the cardiovascular system in a timely manner.

In addition, benzalantamine may increase gastric acid secretion, which may be a potential threat in patients at risk for peptic ulcer disease or gastrointestinal bleeding. Therefore, such patients should be closely monitored for symptoms of active or latent gastrointestinal bleeding, such as melena, vomiting blood, etc., and seek medical treatment in a timely manner during medication.

At the same time, although it has not been observed in clinical trials, depending on the mechanism of action of the drug, benzalantamine may also cause urogenital diseases such as bladder outflow tract obstruction. Patients should pay attention to urination during medication. If symptoms such as difficulty urinating, frequent urination, and urgency occur, they should seek medical examination in time.

On the respiratory side, patients with a history of asthma or obstructive pulmonary disease need to be particularly cautious when using bengalantamine. Because this drug may affect the function of the respiratory system and aggravate the original respiratory symptoms. Such patients should closely observe their breathing conditions during medication. If symptoms such as dyspnea or worsening wheezing occur, they should stop medication immediately and seek medical treatment.

In summary, although benzalantamine, a drug for treating Alzheimer's disease, has significant efficacy, its possible side effects cannot be ignored. Patients should fully understand the side effects before use, and should pay close attention to their body reactions. If they have any discomfort or abnormal symptoms, they should communicate with their doctor in time and adjust the treatment plan to ensure the safety and effectiveness of the treatment.

Reference link:https://www.drugs.com/pro/zunveyl.html#S12.3